123i-mip-1072
Small moleculeexperimentalImaging agent
Clinical trial activity
2 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2008 (NCT00712829)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 123-iodine
Oral
No
Parenteral
No
Topical
No
Also known as
- 123i-mip-1072
- 123i-mip-1072
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00992745 | Phase 1 | Oct 1, 2009 | Cornell University, Duke University, Molecular Insight Pharmaceuticals, Pacific Coast Imaging, University of California, San Francisco, University of Maryland, Vanguard Urologic Research Foundation, West Coast Radiology Centerse |
| NCT00712829 | Phase 1 | May 1, 2008 | Molecular Insight Pharmaceuticals |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Molecular Insight Pharmaceuticals | For profit | 2 | 2 | 1 | 2008 |
| Cornell University | Academic/Hospital | 1 | 0 | 1 | 2009 |
| Duke University | Academic/Hospital | 1 | 0 | 1 | 2009 |
| Pacific Coast Imaging | Academic/Hospital | 1 | 0 | 1 | 2009 |
| University of California, San Francisco | Academic/Hospital | 1 | 0 | 1 | 2009 |
| University of Maryland | Academic/Hospital | 1 | 0 | 1 | 2009 |
| Vanguard Urologic Research Foundation | Academic/Hospital | 1 | 0 | 1 | 2009 |
| West Coast Radiology Centerse | Academic/Hospital | 1 | 0 | 1 | 2009 |
8 organizations
Page 1 / 1